Eileen Connolly
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer (NCT02977468) | Eileen Connolly | 2017-10-25 |
Track Eileen Connolly automatically
Every clearance here is in the API, with alerts when new ones post.